Joseph K. Belanoff, CEO: Corcept Therapeutics CORT Sell · Filed 25/07/21

Trade details

Type: Insider sale
Amount: $45,319.35
Shares · price: 615 sh · $73.69 a share
Held after: 2,901,370 sh
Stock: Corcept Therapeutics CORT
Person: Joseph K. BelanoffCEO
Trade date: 25/07/17
Filed: 25/07/21
Days to filing: 4 days

Sold under 0.1% of holdings

Share of holding sold: under 0.1%

Corcept Therapeutics trades, last 26 weeks

What else happened in Corcept Therapeutics around then

Filed or reported within 30 days of the trade day · 25/06/17~25/08/16

Joseph K. Belanoff's recent trades

Joseph K. BelanoffCEO
Sell10b5-1 planCorcept Therapeutics
Sell10b5-1 plan
Corcept Therapeutics
CORT
$895.3K
12,837 sh
$895.3K
Filed 06/02
Traded 06/01
Joseph K. BelanoffCEO
Planned sale10b5-1 planCorcept Therapeutics
Planned sale10b5-1 plan
Corcept Therapeutics
CORT
$892K
12,837 sh
$892K
Filed 06/01
Traded 06/01
Joseph K. BelanoffCEO
Sell10b5-1 planCorcept Therapeutics
Sell10b5-1 plan
Corcept Therapeutics
CORT
$2M
40,000 sh
$2M
Filed 05/05
Traded 05/01
Joseph K. BelanoffCEO
Planned sale10b5-1 planCorcept Therapeutics
Planned sale10b5-1 plan
Corcept Therapeutics
CORT
$1.9M
40,000 sh
$1.9M
Filed 05/01
Traded 05/01
Joseph K. BelanoffCEO
Sell10b5-1 planCorcept Therapeutics
Sell10b5-1 plan
Corcept Therapeutics
CORT
$1.3M
26,198 sh
$1.3M
Filed 03/27
Traded 03/25

Joseph K. Belanoff, CEO — sold $45.3K of Corcept Therapeutics CORT · under 0.1% of holdings · 10b5-1 plan | Whalegun